IA
MYOV

IFP Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

IFP Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,454
Closed -$82.8K – 3050
2020
Q2 		$86K Buy
+4,454
New +$60.6K 0.01% 982

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

IFP Advisors's MYOV Position: Q3 2020 in Review

IFP Advisors sold out of Myovant Sciences Ltd. (MYOV) in Q3 2020, closing a stake of 4,454 shares — an estimated $82.8K sold.

IFP Advisors first reported a position in MYOV in Q2 2020 and held it in 1 quarter. The position peaked at $86K in Q2 2020. 102 funds tracked by Wall St. Rank hold MYOV as of Q3 2020.

  • IFP Advisors reported no remaining Myovant Sciences Ltd. position as of Q3 2020 after selling out during the quarter.
  • IFP Advisors sold 4,454 Myovant Sciences Ltd. shares in Q3 2020, an estimated $82.8K.
  • IFP Advisors first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 1 quarter.
  • IFP Advisors's Myovant Sciences Ltd. position peaked at $86K in Q2 2020.
  • 102 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2020.

Based on IFP Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.